Introduction
Postpartum hemorrhage (PPH) is a leading cause of maternal morbidity and mortality throughout the world. 1 PPH is estimated to occur in 6-11% of births worldwide and several studies have shown that the incidence of PPH increased in several countries during the 1990s and 2000s. [2] [3] [4] [5] In the United States, the incidence is estimated at approximately 3% and also increased during this time period. 1 The most common cause of PPH is uterine atony (accounting for at least 80% of cases of PPH), with genital trauma (lacerations, incisions, uterine rupture, and others), retained placenta, and coagulopathy comprising other major etiologies. 6 Predisposing risk factors for PPH include maternal epidemiologic characteristics (increased maternal age, parity), obstetrical characteristics (gestational age, induction and augmentation of labor, cesarean delivery), and sociodemographic characteristics (race, income, hospital type and location). [7] [8] [9] [10] [11] [12] The association of PPH with increased maternal mortality is well established. 5, 13 It has furthermore been suggested that PPH contributes disproportionately to severe maternal morbidity.
14 Maternal morbidity and mortality are of significant importance not only to individual patients and clinicians, but also those involved in health policy research and development. Authors have advocated for populationbased observational studies to strengthen the available epidemiologic evidence regarding PPH. 15 To this end, we used data from the National Inpatient Sample (NIS) to analyze a large sample of hospital-based deliveries and examine the association of PPH with clinical outcomes including hospital length of stay (LOS) and inpatient mortality.
Materials and Methods

Institutional review board exemption
This study was exempt from institutional review board approval given that it involved collection of existing data via a large database in such a manner that the subjects could not be identified at any time, directly or through identifiers linked to the subjects.
National Inpatient Sample
The NIS is a component of the Healthcare Cost and Utilization Project (HCUP) sponsored by the Agency for Healthcare Research and Quality. The NIS database is the largest publically available all-payer inpatient databases in the United States. 16 Beginning in 2012, the NIS underwent a redesign initiative, and the NIS presently approximates a 20% stratified sample of discharges from across all US HCUP hospitals (excluding rehabilitation and long-term acute care The redesign was intended to allow more representative sampling of hospital factors including urban-rural location, teaching status, and bed size category, as well as several patient-specific factors.
Patient identification
For primary study purposes, we used NIS data from 2012 through 2013, as these years are the most recent available data collected under the revised sampling design. To identify hospitalizations for childbirth, we used criteria demonstrated in a previous study. 18 To identify PPH we searched for International Classification of Diseases, Ninth Revision (ICD-9), Clinical Modification codes 666.0-666.3. Patients with 1 PPH code were further categorized as atonic or nonatonic; those with a uterine atony plus another PPH code were considered nonatonic. We also identified patients who received different transfusions using ICD-9 codes 99.03 (whole blood), 99.04 (packed cells), 99.05 (platelets), and 99.06 (coagulation factors). Multiparous deliveries were identified by ICD-9 codes 651.0-651.9 (excluding 651.7).
Statistical methods
All analyses were performed using software (SAS, Version 9.4, SAS Institute, Cary, NC). Characteristics between PPH and non-PPH women in the sample were compared using a t test or c 2 tests as appropriate. The clinical outcomes analyses took the sampling design into consideration using SAS PROC SUR-VEYREG and PROC SURVEYFREQ procedures. The significant c 2 tests were subsequently analyzed with pairwise comparisons in a procedure described by Sharpe. 19 We analyzed age, race, income (by ZIP code quartiles), insurance status, and hospital type/location. Patients missing data on in-hospital mortality were treated as alive at discharge. All other missing data were handled using complete-case analysiseobservations missing any of our variables of interest were excluded from the analysis. Inhospital mortality was summarized by number of in-hospital deaths per 1000 hospitalizations. Comparisons were made by calculating the risk difference (95% confidence interval [CI]). LOS was summarized by mean (95% CI), with comparisons being made by mean difference (95% CI). These analyses used SAS PROC GENMOD to account for the NIS sampling design. For each regression model, we also assessed the association between outcomes adjusting for race, multiparity, and hospital type. In addition to comparing LOS and mortality, we assessed whether there were any trends over time using earlier years of the NIS. Trend weights provided by HCUP were used with data from 2004 through 2011. We plotted summary statistics for both clinical outcomes over a 10-year period.
Results
Sociodemographic characteristics
NIS data from 2012 through 2013 contained 1,470,371 hospitalizations for birth that met inclusion criteria. Using complete-case analysis, we dropped 8% of our sample; the final analysis data set included 1,352,691 hospitalizations. Delivery characteristics, including the classifications of PPH, are displayed in Table 1 . The most common classification of PPH was uterine atony (76.6%). Other classifications included retained placenta (8.4%), delayed/secondary (8.1%), and coagulation defects (7.4%).
Comparison of clinical and sociodemographic factors between deliveries complicated by PPH and non-PPH deliveries is shown in Table 2 . Multiparity was more likely in both atonic and nonatonic PPH vs non-PPH deliveries. Hysterectomy was significantly more frequent in nonatonic PPH compared to atonic PPH and non-PPH deliveries. Further analysis regarding race demonstrated that atonic PPH was more likely in Hispanic women, while nonatonic PPH and non-PPH deliveries were more common in White women. While the c 2 test was significant for comparison of insurance, subsequent analyses did not suggest there were any meaningful differences in any pairwise comparisons. Conversely, there were significant differences for all pairwise comparisons of hospital type, hysterectomy, and all transfusion types, excepting whole blood products.
Hospital LOS
Mean hospital LOS and mortality are shown in Table 3 . Hospital LOS was greatest for nonatonic PPH hospitalizations (3.67 days), followed by atonic PPH (2.98 days). LOS was shortest in deliveries not complicated by PPH (2.63 days). Nonatonic PPH LOS was 1.04 days longer on average than deliveries not complicated by PPH (95% CI, 0.93e1.14; P < .001). After adjusting for race, multiparity, and hospital type, the average difference was 0.97 days (P < .001). Atonic PPH LOS was 0.35 days longer on average than deliveries not complicated by PPH (95% CI, 0.31e0.39; P < .001). After adjusting for Figure 1 .
In-hospital mortality
In-hospital mortality was rare. There were 58 deaths recorded; 42 among deliveries not complicated by PPH (3.2 per 100,000), 6 among deliveries complicated by atonic PPH (19.0 per 100,000), and 10 among deliveries complicated by nonatonic PPH (103.5 per 100,000). Of in-hospital mortality events during the study period, 27.6% There was almost no change in the difference after adjusting for race, multiparity, and hospital type ( Table 3 ). The risk difference between nonatonic PPH and non-PPH deliveries was 0.1% (95% CI, 0.036e0.164; P ¼ .002). Similarly, adjusting for race, multiparity, and hospital type did not affect the risk difference (0.099%; P ¼.002) ( Table 3 ). Using the trend weights for earlier years, inhospital mortality from 2004 through 2013 is shown in Figure 2 .
Comment
We used contemporary NIS data to analyze the association between PPH and hospital LOS and inpatient mortality, and found that PPH was associated with a small but statistically longer hospital LOS in both unadjusted and adjusted analyses. PPH was also associated with increased mortality in the unadjusted analysis and the adjusted analysis, although absolute risk differences were small. This is one of the first studies to focus on hospital LOS in addition to maternal mortality, and thus represents an important addition to the literature with regards to both patient morbidity as well as a measure of the health policy and economic impact of PPH on the national medical system as a whole. While we found an association between PPH and maternal mortality, the association was not as robust as suggested by prior studies. 3, 5, 7 Some of this discordance may have been affected by the low mortality rate across the entire sample, possibly reflecting recent improvements in care of women with PPH in the United States (especially as many of the prior studies utilized data derived from earlier time periods). Furthermore, the majority of PPH cases were atonic but the majority of maternal deaths due to PPH were nonatonic, and nonatonic PPH was associated with increased mortality; this may be an area of focus for further investigation. There may also be regional variations in the care of women with PPH that were not possible to detect with the small number of maternal deaths in this sample. 20 An important strength of this study is the very large sample size provided by the NIS database. We believe that this database is representative of current peripartum data, including PPH, across the United States given that NIS data include information from a variety of geographic locations, hospital types, and insurance plans. As such, these data are likely generalizable to the US population as a whole. Additionally, the recent timing of the available data (2012 through 2013) allows for accurate analysis of recent temporal developments in PPH morbidity and mortality. Finally, this is one of the first studies to examine the impact of PPH on inpatient LOS in addition to mortality, and therefore provides additional novel data for clinicians, health economists, and specialists in health care policy. For example, an ad hoc estimation of financial impact extrapolated from LOS data as well as institutional data regarding charges for inpatient daily obstetric charges suggested an increased cost of approximately $106.7 million annually attributable to increased LOS in the setting of PPH (Dr Carl Rose, MD, oral communication, February 20, 2017).
There are several limitations of this study. Inherent to studies utilizing retrospective administrative data, patients were included based on discharge diagnosis, which is subject to error and/ or misclassification bias. Such bias may vary based on hospital geographic location and type, and there may be further potential bias given that there is no uniform definition of PPH, uterine atony, coagulopathy, or many of the other classification categories necessary for this study. Classification and recording of blood product transfusions may also not be performed uniformly. As these variables were used for the multivariate regression analysis, misclassification and underreporting or overreporting may have influenced the results of the analysis. Further prospective research using uniform classification criteria for PPH and medical comorbidities and procedures would be helpful in confirming our findings. Additionally, [21] [22] [23] However, despite such promising developments, PPH continues to contribute to maternal death and disability in all regions of the world. We found that PPH was associated with several sociodemographic patient characteristics as well as longer hospital LOS, which is of importance in both the clinical as well as the health care policy realms. Maternal and neonatal hospital stays account for >20% of all inpatient hospitalizations in the United States, including almost half of stays among patients aged 18-44 years. 24 Increased LOS is associated with increased costs and risk of complications, and imparts implications for infection and venous thromboembolism prophylaxis, among other areas. Further studies could focus on specific determinants of PPH FIGURE 2 In-hospital mortality based on postpartum hemorrhage (PPH) status A, While overall inpatient mortality rates for all women were low, mortality was higher for women with than without PPH, primarily due to nonatonic PPH. B, Inpatient mortality was highest with nonatonic PPH, primarily due to coagulation defects. Original Research OBSTETRICS ajog.org incidence and complications and tailor interventions to geographic areas, patient populations, and hospital types with the greatest need for intervention to reduce the adverse consequences of this potentially preventable pregnancy complication. Additionally, such data would be a helpful supplement to protocols already in use for identifying and responding to PPH. 25 
Conclusion
Using data from the NIS from 2012 through 2013, we found that women with PPH experienced significantly longer LOS and higher inpatient mortality rates than women without PPH. The preponderance of these differences were attributable to nonatonic causes of PPH. While the association between PPH and increased mortality risk was previously reported, this is one of the first studies to also report the association between PPH and increased hospital LOS. LOS, in addition to mortality, is an important area of focus for clinicians and health care policy specialists. Interventions to reduce mortality and morbidity (including increased LOS) related to PPH may allow for delivery of more cost-effective care as well as overall improvements in maternal and population health. n
